These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 7962870)

  • 1. Measuring the fidelity of implementation of a mental health program model.
    McGrew JH; Bond GR; Dietzen L; Salyers M
    J Consult Clin Psychol; 1994 Aug; 62(4):670-8. PubMed ID: 7962870
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness of an assertive outreach community treatment program.
    Dharwadkar N
    Aust N Z J Psychiatry; 1994 Jun; 28(2):244-9. PubMed ID: 7993278
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Critical ingredients of assertive community treatment: judgments of the experts.
    McGrew JH; Bond GR
    J Ment Health Adm; 1995; 22(2):113-25. PubMed ID: 10142125
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expert ratings on the critical ingredients of supported employment for people with severe mental illness.
    Evans LJ; Bond GR
    Psychiatr Rehabil J; 2008; 31(4):318-31. PubMed ID: 18407882
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of experts' perspectives on assertive community treatment and intensive case management.
    Schaedle R; McGrew JH; Bond GR; Epstein I
    Psychiatr Serv; 2002 Feb; 53(2):207-10. PubMed ID: 11821553
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prediction of outcome from the Dartmouth assertive community treatment fidelity scale.
    Bond GR; Salyers MP
    CNS Spectr; 2004 Dec; 9(12):937-42. PubMed ID: 15616478
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of new long-stay patients.
    Davies S; Payne S; Jenkins J
    Br J Psychiatry; 1994 Dec; 165(6):840-1. PubMed ID: 7881796
    [No Abstract]   [Full Text] [Related]  

  • 8. Case managers' perspectives on critical ingredients of assertive community treatment and on its implementation.
    McGrew JH; Pescosolido B; Wright E
    Psychiatr Serv; 2003 Mar; 54(3):370-6. PubMed ID: 12610246
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of Assertive Community Treatment Fidelity Assessment Methods: Reliability and Validity.
    Rollins AL; McGrew JH; Kukla M; McGuire AB; Flanagan ME; Hunt MG; Leslie DL; Collins LA; Wright-Berryman JL; Hicks LJ; Salyers MP
    Adm Policy Ment Health; 2016 Mar; 43(2):157-67. PubMed ID: 25721146
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fidelity to assertive community treatment and client outcomes in the New Hampshire dual disorders study.
    McHugo GJ; Drake RE; Teague GB; Xie H
    Psychiatr Serv; 1999 Jun; 50(6):818-24. PubMed ID: 10375153
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of a managed mental health program on Medicaid recipients with severe mental illness.
    Stroup TS; Dorwart RA
    Psychiatr Serv; 1995 Sep; 46(9):885-9. PubMed ID: 7583497
    [No Abstract]   [Full Text] [Related]  

  • 12. The development of de-institutionalization in Europe.
    Uffing HT; Ceha MM; Saenger GH
    Psychiatr Q; 1992; 63(3):265-78. PubMed ID: 1488466
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A model for measuring the implementation of community support programs: results from three sites.
    Brekke JS; Test MA
    Community Ment Health J; 1992 Jun; 28(3):227-47. PubMed ID: 1611865
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fidelity to recovery-oriented ACT practices and consumer outcomes.
    Cuddeback GS; Morrissey JP; Domino ME; Monroe-DeVita M; Teague GB; Moser LL
    Psychiatr Serv; 2013 Apr; 64(4):318-23. PubMed ID: 23318948
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assertive community treatment for people with severe mental illness: the effect on hospital use and costs.
    Salkever D; Domino ME; Burns BJ; Santos AB; Deci PA; Dias J; Wagner HR; Faldowski RA; Paolone J
    Health Serv Res; 1999 Jun; 34(2):577-601. PubMed ID: 10357291
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assertive community treatment across the Atlantic: comparison of model fidelity in the UK and USA.
    Fiander M; Burns T; McHugo GJ; Drake RE
    Br J Psychiatry; 2003 Mar; 182():248-54. PubMed ID: 12611789
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A four-year retrospective study of Assertive Community Treatment: change to more frequent, briefer client contact.
    Gold PB; Jones DR; Macias C; Bickman L; Hargreaves WA; Frey J
    Bull Menninger Clin; 2012; 76(4):314-28. PubMed ID: 23244525
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Program fidelity and beyond: multiple strategies and criteria for ensuring quality of assertive community treatment.
    Monroe-DeVita M; Morse G; Bond GR
    Psychiatr Serv; 2012 Aug; 63(8):743-50. PubMed ID: 22508406
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The teamwork in assertive community treatment (TACT) scale: development and validation.
    Wholey DR; Zhu X; Knoke D; Shah P; Zellmer-Bruhn M; Witheridge TF
    Psychiatr Serv; 2012 Nov; 63(11):1108-17. PubMed ID: 22948786
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Development of a fidelity scale for function assertive community treatment (FACT)].
    van Vugt MD; van Veldhuizen JR; Bahler M; Delespaul P; Huffels N; Mulder CL; Nijboer G; Overdijk M; Kroon H
    Tijdschr Psychiatr; 2011; 53(2):119-24. PubMed ID: 21319068
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.